500k sale between Friday and yesterday.
Please spare me your insults, I understand the reasons and implications, I just want to share the info because once upon a time that is what this board was used for.
LOL meat *is* murder -- tasty tasty murder!
an anonymous poster offered up the Erkki email. Obviously you believe that the email is legitimate. Maybe you should follow your own advice about believing what's posted on these boards!
but why listen to me, what do I know?
kc, I don't know but just like that, I am in with 264K shares here when I wanted only 100-150K shares. Had another order at 12 cents but it didn't fill. If this pattern repeats tomorrow and we go below 12, I might be hitting my ex-BMGP levels in terms of shares owned! Hate it when I do impulse buys :)...
I doubled up to 225K shares now. This is ludicrous unless there is some bad news in the horizon. What could it be? It will take something like Lanza leaving the company or a major patent dispute but both are far fetched conspiracy theories.
With good results, I expect a JV, or outright buyout, considering the plight of "big pharma's" pipelines at this time. What I meant about FDA is that (unless someone got approval that I am not aware of) only ACTC and Geron have FDA approval for human testing in the U.S. Out of the 3 approvals, we have two of them. I agree about the revs. being a long way off, but I am only looking for price appreciation, which doesn't require revs., just the prospect of revs. as seen by a potential partner. JMHO
the stock is getting crushed plain and simple. what a nightmare. not for insiders however they gain in the sea of red. anyone who doesnt see something wrong with that picture is missing something or doesnt care about regular type shs. free shares for insiders selling and millions of them will hold this down. how many more bod members are there left to go. what does this eriki guy even do to cash in for over a hundred grand? i mean does he do anything other then gift himself shares. what a great job. i mean do at actc that is. seriously what does he do at actc. that seems like a pretty honest question
kc, could you elaborate on what you mean by "2/3 of the FDA approved trials in our pocket". You mean as far as timelines to get started on the Ph I/II trials or FDA's sentiment on this therapy?
I don't see any revenue coming for a few years but as you know, the market is always forward looking and any good results from the trials will account for future valuations pretty quickly. My only concern is further dilution. I am hoping with the last one, they are good till Ph III. Or a partnership will alleviate that concern. 1.4 billion shares is a lot.....